Human ALG14 activation kit by CRISPRa
CAT#: GA116321
ALG14 CRISPRa kit - CRISPR gene activation of human ALG14 UDP-N-acetylglucosaminyltransferase subunit
CNY 12,255.00
CNY 2,400.00
CNY 3,705.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | ALG14 |
Locus ID | 199857 |
Kit Components | GA116321G1, ALG14 gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA116321G2, ALG14 gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA116321G3, ALG14 gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Disclaimer | These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001305242, NM_144988, NR_131032 |
Synonyms | CMS15 |
Summary | This gene is a member of the glycosyltransferase 1 family. The encoded protein and ALG13 are thought to be subunits of UDP-GlcNAc transferase, which catalyzes the first two committed steps in endoplasmic reticulum N-linked glycosylation. Mutations in this gene have been linked to congenital myasthenic syndrome (CMSWTA). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN404062 | ALG14 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8,680.00 |